Structure (Pirfenidone 01)
Pirfenidone Tablet, Film Coated
Product Images NDC 0781-8086
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 0781-8086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig-1 (Pirfenidone 02)
This text appears to be a chart showing the percentage of patients who experienced a decline, no change, or an increase in FVC (forced vital capacity) while taking Pirfenidone versus placebo. The chart displays the percentages for each category and includes an absolute change in FVC from baseline to week 52.*
Fig-2 (Pirfenidone 03)
Fig-3 (Pirfenidone 04)
Dosing-schedule (Pirfenidone 05)
This is a dosing schedule for Pirfenidone Tablets, which come in two strengths: 267 mg and 801 mg. The dosing for the 267 mg tablets is shown for the first two weeks with an increase in the number of pills taken each day from 3 to 9. The dosing for the 801 mg tablets is shown for the duration of treatment with 1 tablet taken 3 times a day.*
267mg-label (Image 01)
801mg-label (Image 02)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
